Arsenic and aspartate aminotransferase increased Patient Reports February 12, 2012
Arsenic Side Effects Report #5081598-X
Arsenic side effect was reported by a Physician from JAPAN on July 27, 2006. Female patient, 76 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood fibrinogen increased, blood lactate dehydrogenase increased, fibrin d dimer increased, gamma-glutamyltransferase increased. Arsenic dosage: 9.285 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CEFPIROME SULPHATE, MICAFUNGIN, ACYCLOVIR. Patient was hospitalized. Patient recovered.
Arsenic Side Effects Report #4940793-8
Arsenic side effect was reported by a Physician from JAPAN on Feb 21, 2006. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Arsenic dosage: 9.3 MG QD INTRAVENOUS DRIP. During the same period patient was treated with NAFAMOSTAT MESILATE. Patient was hospitalized. Patient recovered.
Arsenic Side Effects Report #4947831-7
Arsenic side effect was reported by a Physician from JAPAN on Mar 02, 2006. Female patient, 36 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Arsenic dosage: 8.1 MG QD INTRAVENOUS. During the same period patient was treated with CEFEPIME DIHYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, MICAFUNGIN, SULFAMETHOXAZOLE W. Patient recovered.
Arsenic Side Effects Report #5390025-4
Arsenic side effect was reported by a Health Professional from CHINA on June 29, 2007. Female patient was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic failure, therapeutic agent toxicity. Arsenic dosage: 10MG IN 250ML OF 5% DEXTROSE DAILY INTRAVENOUS DRIP. Patient died.
Arsenic Side Effects Report #5390027-8
Arsenic side effect was reported by a Physician from CHINA on June 29, 2007. Female patient was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic failure, therapeutic agent toxicity. Arsenic dosage: 10MG IN 250ML OF 5% DEXTROSE DAILY INTRAVENOUS DRIP. Patient died.
Arsenic and aspartate aminotransferase increased 